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ABSTRACT
OBJECTIVE: To analyze the coverage of a cervical cancer screening program 
in a city with a high incidence of the disease in addition to the factors 
associated with non-adherence to the current preventive program. 
METHODS: A cross-sectional study based on household surveys was 
conducted. The sample was composed of women between 25 and 59 years 
of age of the city of Boa Vista, RR, Northern Brazil who were covered by 
the cervical cancer screening program. The cluster sampling method was 
used. The dependent variable was participation in a women’s health program, 
defined as undergoing at least one Pap smear in the 36 months prior to the 
interview; the explanatory variables were extracted from individual data. A 
generalized linear model was used.
RESULTS: 603 women were analyzed, with an mean age of 38.2 years 
(SD = 10.2). Five hundred and seventeen women underwent the screening 
test, and the prevalence of adherence in the last three years was up to 85.7% 
(95%CI 82.5;88.5). A high per capita household income and recent medical 
consultation were associated with the lower rate of not being tested in 
multivariate analysis. Disease ignorance, causes, and prevention methods 
were correlated with chances of non-adherence to the screening system; 
20.0% of the women were reported to have undergone opportunistic and 
non-routine screening.
CONCLUSIONS: The informed level of coverage is high, exceeding the 
level recommended for the control of cervical cancer. The preventive program 
appears to be opportunistic in nature, particularly for the most vulnerable 
women (with low income and little information on the disease). Studies on 
the diagnostic quality of cervicovaginal cytology and therapeutic schedules 
for positive cases are necessary for understanding the barriers to the control 
of cervical cancer.
DESCRIPTORS: Uterine Cervical Neoplasms, prevention & control. 
Cervix Neoplasms Prevention. Papanicolaou Test. Health Services 
Coverage. Mass Screening. 
Original Articles DOI:10.1590/S0034-8910.2015049005554
Cibelli NavarroI
Allex Jardim da FonsecaI
Alexander SibajevI
Camila Iasmim de Andrade SouzaII
Daniela Souza AraújoII
Daniele Aparecida de Freitas TelesII
Stéphanie Gomes Lins de 
CarvalhoII
Kyldery Wendell Moura 
CavalcanteII
Wendell Lima RabeloII
2 Cervical cancer screening Navarro C et al
Although cervical cancer (CC) is a neoplasm with 
great potential for prevention, it is still an important 
public health problem in Brazil, leading to the highest 
number of deaths in young women (15-44 years old).a 
Until 2013, the Ministry of Health’s efforts to control 
CC were exclusively focused on using the vaginal 
smear (Pap smear) for screening the sexually active 
female population (25-64 years).b Nearly 16,000 new 
cases of CC have been estimated in Brazil in 2014 
(15.3/100,000).c
RESUMO
OBJETIVO: Analisar a cobertura do programa de rastreamento do câncer do colo 
uterino em município com alta incidência da doença e os fatores relacionados 
à não adesão ao programa preventivo vigente.
MÉTODOS: Foi realizado estudo transversal, com base em inquérito domiciliar. 
A amostra foi composta por mulheres entre 25 e 59 anos de idade do município 
de Boa vista, RR, Brasil, com cobertura pelo programa de rastreamento do câncer 
do colo uterino. Foi utilizado o método de amostragem por conglomerado. A 
variável dependente foi a adesão ao programa de saúde da mulher, definida 
como a realização de pelo menos um teste de Papanicolaou nos 36 meses 
anteriores à data da entrevista; as variáveis explicativas foram extraídas a partir 
de informações individuais. Foi utilizado modelo linear generalizado.
RESULTADOS: Foram analisadas 603 mulheres, com idade média de 38,2 anos (DP 
= 10,2). Quinhentas e dezessete mulheres realizaram o exame, sendo a prevalência 
de realização, nos últimos três anos, de 85,7% (IC95% 82,5;88,5). Renda familiar 
per capita elevada e consulta médica recente associaram-se à menor taxa de não 
realização do exame na análise multivariada. O desconhecimento da doença, das 
causas e dos meios de prevenção correlacionou-se com a chance de não adesão 
ao rastreamento. Vinte por cento das mulheres relataram realização do exame 
em caráter oportunístico, e não rotineiro.
CONCLUSÕES: A cobertura informada é elevada, acima do recomendado para 
controle do câncer do colo uterino. O programa preventivo apresenta caráter 
oportunístico, sobretudo para as mulheres mais vulneráveis (com baixa renda 
e pouca informação sobre a doença). Estudos sobre a qualidade diagnóstica 
da citologia cervicovaginal e dos itinerários terapêuticos dos casos positivos 
são necessários para compreensão das barreiras para o controle do câncer do 
colo uterino.
DESCRITORES: Neoplasias do Colo do Útero, prevenção & controle. 
Prevenção de Câncer de Colo Uterino. Teste de Papanicolaou. 
Cobertura de Serviços de Saúde. Programas de Rastreamento.
INTRODUCTION
In Northern Brazil, CC is an even bigger problem. 
The National Cancer Institute estimates an incidence 
of 26.6/100,000 in 2014 for the city of Boa Vista, RR, 
Northern Brazil, which has remained stable in recent 
years. However, a population-based study conducted 
in the state in 20107 revealed a higher cervical cancer 
incidence than official estimates (46/100,000).
Several factors, such as the cultural characteristics of 
the native people, geographic isolation, limitations of 
a  World Health Organization. ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and 
cervical cancer statistics in Brazil. Geneva; 2014 [cited 2014 Jan 1]. Available from: http://www.hpvcentre.net
b Ministério da Saúde. Instituto Nacional de Câncer. Coordenação Geral de Ações Estratégicas. Divisão de Apoio à Rede de Atenção 
Oncológica. Diretrizes brasileiras para o rastreamento do câncer do colo de útero. Brasília (DF); 2014 [cited 2014 Jan 1]. Available from: 
http://www1.inca.gov.br/inca/Arquivos/PROGRAMA_UTERO_internet.PDF
c Ministério da Saúde. Incidência de Câncer no Brasil: estimativa 2014. Brasília (DF); 2014 [cited 2014 Jan 1]. Available from: http://www.
inca.gov.br/estimativa/2014
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the Pap smear test, failures in the follow-up of pre-
malignant lesions, and adoption of improper conduct, 
may contribute toward explaining the partial success 
of screening programs in Northern Brazil.8,12 The popu-
lation coverage of the preventive strategy is a crucial 
factor in this process. In Brazil, aspects associated with 
availability and access to the health systems have been 
widely studied and identified as a limitation in control-
ling CC in several regions.1,6
Regions with a high incidence of CC usually present 
predominantly opportunistic screening programs 
(contrary to systematic and organized programs) that 
provide limited coverage, generate multiple tests for 
the same individual, and tend to neglect the women 
who would benefit the most from the screening test.11 
An awareness of the scope of preventive programs and 
factors associated with poor adherence to the proposed 
model can help in drafting public policies that are 
more efficient and better aligned with the status of 
each region.
The objective of this study was to analyze the coverage of 
a cervical cancer screening program in a city with a high 
incidence of the disease as well as the factors associated 
with non-adherence to the current preventive program.
METHODS
This cross-sectional study using household surveys 
was conducted in Boa Vista, Roraima, a city with a 
population of 285,000 inhabitants located in Legal 
Amazonia in Northern Brazil. Approximately 65.0% 
of the state’s population is concentrated in Boa Vista,d 
and the Family Health Strategy covers 75.0% of its 
population. The target population of the study included 
women aged 25-59 years living in the city for at least 
three years. Although the Ministry of Health has 
recently extended the age range of the target population 
to 64, the cut-off of 59 years was used as this study is 
retroactive to the period when the previous limit was 
applicable. Considering the estimated prevalence of 
80.0% coverage for CC screening based on a national 
surveyb conducted in 2008 by the Brazilian Institute for 
Geography and Statistics (IBGE) and assuming normal 
distribution for 95% confidence interval (95%CI) and 
an acceptable error of 5%, a minimum sample size of 
550 participants was obtained, assuming a 10.0% loss. 
To evaluate the risk factors, the sample size has a 90.0% 
power for detecting an adjusted odds ratio of > 1.5 with 
a 95%CI, assuming a rejection rate of 10.0%.
The random cluster sampling method was used. The 
neighborhoods in Boa Vista’s urban area comprise 
4,902 blocks. These were numbered and selected by a 
random number generator software. The selected blocks 
d  Instituto Brasileiro de Geografia e Estatística. Censo 2010. Brasília (DF); 2010 [cited 2014 Jan 1]. Available from: http://www.ibge.gov.br/
english/estatistica/populacao/censo2010/caracteristicas_da_populacao/resultados_do_universo.pdf
were adjusted (weighted) for the population in each 
macro area of  the municipality. On weekends between 
June and August 2013, the researchers visited the blocks 
in the order of random selection to investigate the target 
samples. All the women living in the selected block 
were approached in their homes and invited to partic-
ipate. Of these, 208 women were excluded for being 
present but not residing in their homes, not fulfilling 
the age criteria, having resided in another municipality 
in the last three years, or refusing to participate in the 
study. A previously tested form was used in a 30-min 
personal interview at the interviewee’s residence, pref-
erably in the absence of any co-residents.
The primary outcome assessed was participation in 
a women’s health program, defined as undergoing at 
least one Pap smear test in the 36 months prior to the 
interview, regardless of the outcome and location of 
the test. Data collected were sociodemographic data, 
educational level (primary education being the cut-off), 
awareness of human papilloma virus and CC, personal 
and family clinical data, health worker visit, history of 
medical visits, and personal reasons for not being tested.
After the survey, 10.0% of the forms from each inter-
viewer were randomly selected for quality control. 
These selected women were reinterviewed on telephone 
regarding what were considered to be “key” questions. 
The answers to these questions were compared with 
those obtained in the first phase. No questionnaires 
were discarded.
Descriptive statistical analysis included frequency 
distribution for categorical variables and means (stan-
dard deviation) and medians (with interquartile ranges) 
for continuous variables with normal and abnormal 
distribution, respectively. Prevalence was defined as 
the number of women screened at least once in the 
last three years per 100 interviewed volunteers, and it 
was adjusted to the age structure of the municipality. 
Further, 95%CI was estimated based on binomial distri-
bution. To compare the sampling means, Student’s t test 
was used for the normal distribution of variables and 
homogeneity of sample variances. For the other vari-
ables, the Mann-Whitney test was used. The Chi-square 
test was used to compare differences in the proportions 
of categorical variables. Odds ratio (OR) and 95%CI 
were calculated using bivariate analysis and adjusted 
odds ratio (ORa) in multivariate logistic regression anal-
ysis. The criterion for selecting explanatory variables 
for entry into the multivariate analysis was the critical 
value of p < 0.15 in the bivariate analysis. Data were 
tabulated using double entry and analyzed using the 
EpiInfo version 7.1.3 software (CDC, Atlanta, USA).
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This study was approved by the Ethics Committee of 
Universidade Federal de Roraima (Process 111.007 – 
CEP/UFRR). All study participants signed the informed 
consent form.
RESULTS
Of the 603 study participants (mean age), 54.8% were 
married or in a stable relationship. Almost half 
(46.0%) had completed high school, with only 
1.6% being illiterate (1.6%) and 28.6% having 
complete or incomplete higher education (Table 1). 
Furthermore, 517 had undergone a screening test in 
the last three years, with an adjusted prevalence of 
adherence of 85.6% (95%CI 82.5;88.5), and 443 had 
been tested in the last year, with a prevalence of 
72.8% (95%CI 68.6;77.0). The highest prevalence of 
adherence (90.0%) was observed in the 20-34-year 
age group, and the lowest in the 50-54-year age 
group (76.0%) (Figure 1). Periodic routine was the 
main reported reason for undergoing the preventive 
screening (n = 411; 79.5%). Other reasons provided 
by 20.5% of the women included pregnancies, gyne-
cological complaints, and visits to the clinic for other 
reasons. Table 2 describes the characteristics of the 
women who did not adhere to the preventive screening.
Among the 86 volunteers who had never undergone 
the screening test, 75.6% did not explain not getting 
tested, 10.5% reported shame or fear, 5.8% stated they 
did not think it was necessary, 2.4% reported difficulty 
scheduling an appointment or finding time for it, and 
2.4% reported other personal reasons. The lack of time, 
interest, and medical recommendation were the reasons 
reported by three other women (1.1% each).
The prevalence of adherence to the preventive program 
was similar among women under 35 years of age and 
older than 35 years (12.0% versus 16.0%, respectively). 
The marital status and educational level did not change the 
rate of non-adherence to the screening. Table 3 shows indi-
vidual variables and variables of awareness of the disease 
with non-adherence to the program for preventing CC.
Two individual variables were shown to influence 
the frequency of non-adherence to the screening 
in univariate analysis, and these were re-evalu-
ated in multivariate analysis, namely (i) medical 
visit in the last year compared with women without 
medical visit (8.8% versus 34.6%; p < 0.0001) and 
(ii) household income per capita of > R$1,000.00 
in association with household income per capita 
of < R$1,000.000 (5.9% versus 16.6%; p < 0.001). 
Of these, medical visits in the previous year had 
the greatest influence on the outcome, reducing the 
chance of non-adherence by approximately 60.0% 
(ORa = 0.4, 95%CI 0.1;0.7). Of the five variables 
regarding disease awareness and prevention, four 
Table 1. Socioeconomic data, knowledge about the disease 
and lifestyle in women aged 25-59 years. Boa Vista, RR, 
Northern Brazil, 2013. (N = 603)
Personal and demographic data n %
Conjugal status
Married/Stable union 330 54.8
Single 212 35.3
Widowed/Separated 60 9.9
Education
Illiterate 10 1.6
Primary education 144 23.8
High school 277 46.0
Higher education 136 22.6
Postgraduate education 36 6.0
Have a health plan or health insurance
Yes 85 14.1
No 509 84.4
No response 9 1.5
Family income per capita
≤ R$1,000.00 464 77.0
> R$1,000.00 119 19.7
No response 20 3.3
Receive government financial assistance
Yes 260 43.1
No 343 56.9
Number of inhabitants in the household
> 5 people 114 18.9
≤ 5 people 489 81.1
Smoking
Yes 166 27.5
No 437 72.5
Regular use of alcohol
Yes 26 4.3
No 577 95.7
Family history of cervical cancer
Yes 96 15.9
No 507 84.1
Medical visit in the last year
Yes 476 79.0
No 127 21.0
Received home visit from health professionals during the 
study period
Yes 155 25.7
No 447 74.3
Know that cervical cancer is caused by a virus
Yes 100 16.6
No 503 83.4
Know what virus causes cervical cancer
Yes 100 16.6
No 503 83.4
Know what test detects cervical cancer
Yes 565 93.7
No 38 6.3
Know when screening begins
Yes 329 54.6
No 274 45.4
Know how frequently screening is done
Yes 313 51.9
No 290 48.1
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influenced the outcome. Being aware of the caus-
ative virus reduced the prevalence of non-adherence 
by 10 percentage points compared to the rate among 
women who were unaware (6.0% versus 16.9%, 
respectively; ORa = 0.5; 95%CI 0.2;0.8). Information 
of the test that detects CC led to a lower prevalence 
of non-adherence (13.2% versus 29.0%, respectively; 
ORa = 0.5; 95%CI 0.2;0.9). The other assessed vari-
ables were not statistically significant.
DISCUSSION
The prevalence of the coverage of the preventive 
screening in Boa Vista was 85.6%. Two variables were 
associated with non-adherence to screening: per capita 
income exceeding R$1,000.00 and having received 
medical consultation in the last year.
This study assessed the coverage of a preventive 
program based on Pap smear testing in the city of Boa 
Vista, Roraima, Northern Brazil as a function of the 
high incidence rate of CC in this location, according 
to a recent population-based study.7 In 2008, IBGE 
released the results of the Pesquisa Nacional por 
Amostra de Domicílios (PNAD – National Household 
Sample Survey)e referring to the access to and use 
of health services, among other data. In this survey, 
72.7% of the female residents of Roraima aged 25-60 
years claimed to have undergone the screening test, 
while this number was 76.9% for the Northern region 
and 78.4% for the country as a whole. Data from 
the 2012 Sistema de Vigilância de Fatores de Risco 
e Proteção para Doenças Crônicas por Inquérito 
Telefônico (VIGITEL – Chronic Disease Risk Factor 
Monitoring and Protection System Telephone Survey)f 
conducted by the Ministry of Health has revealed that 
79.6% of women in Roraima stated undergoing 
screening in the last three years, and this prevalence 
of adherence exceeds the national average.
In this study, the prevalence of women tracked over 
the last three years was 85.6%, similar to that in 
the VIGITEL data.f The prevalence of women who 
reported undergoing the screening test in the last 
year was similar to that obtained from IBGE (72.7%). 
According to the World Health Organization (WHO), 
80.0% population coverage is sufficient for markedly 
reducing the incidence of and mortality from CC,a as 
registered in the Brazilian state of Paraná, wherein 
mortality from CC was reduced by 50.0% after a task 
force expanded the screening coverage from 60.0% to 
86.0% between 1997 and 2002.3 However, a different 
scenario is observed in this study because Boa Vista 
still has a high incidence of the disease despite a high 
coverage rate.
Some factors may explain this paradox. For the 
women who were adherent to the screening strategy, 
more than 20.0% underwent testing for opportunistic 
reasons (pregnancy, medical appointment, or particu-
larly, gynecological complaints). When women have 
complaints, such as itching and leukorrhea, they seek 
medical attention and are advised to undergo preven-
tive testing.12 This model is associated with women’s 
perception that the test is only necessary in case of 
e Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílio: PNAD 2008. Um Panorama da Saúde no Brasil 
- Acesso e utilização dos serviços, condições de saúde e fatores de risco e proteção à saúde 2008. Brasília (DF); 2008 [cited 2014 Jan 1]. 
Available from: http://www.ibge.gov.br/home/estatistica/populacao/panorama_saude_brasil_2003_2008/PNAD_2008_saude.pdf
f Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção 
de Saúde. Vigitel Brasil 2012: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico / Ministério da Saúde, 
Secretaria de Vigilância em Saúde, Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção de Saúde. Brasília (DF): 
Ministério da Saúde, 2013 [cited 2014 Jan 1]. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2012.pdf
Note: The horizontal line represents the Ministry of Health’s goal for screening coverage.b
Figure. Prevalence of women non-adherent to preventive screening for cervical cancer over a successive three-year period by 
age group (N = 517). Boa Vista, RR, Northern Brazil, 2013.
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illnesses or symptoms; however, it should be routinely 
performed in asymptomatic women. In this study, 
receiving medical consultation in the last year reduced 
the chances of non-adherence with the screening by 
60.0%. One characteristic of opportunistic screening 
programs is the number of tests conducted on the 
same woman, in the same year, and at the expense of 
the exclusion of others who would probably benefit 
from testing.11
Other factors may explain the inefficiency of the 
tracking program in Roraima, such as difficulties 
in the diagnostic confirmation, monitoring, and the 
treatment of intraepithelial and malignant lesions. 
Adequate screening program coverage only helps in 
controlling CC if the subsequent steps are followed. 
Data indicate the low capacity of the Brazilian Unified 
Health System (SUS) laboratory network for identi-
fying intraepithelial lesions,10 failures to follow-up 
positive cases,9 and the lack of adequate human 
resources, particularly in the less-developed regions 
of the country.6,12 The quality of these processes has 
not been investigated in Roraima, indicating the 
need for studies regarding these steps to guide poli-
cies and interventions for effectively controlling CC 
in this state.
The individual factors, such as age, education, and 
marital status did not demonstrate influence on the 
outcome. Low income was the main socioeconomic 
factor associated with non-adherence in this study. 
Albuquerque et al2 have revealed that in Pernambuco, 
Northeastern Brazil, characteristics associated with 
the non-completion of testing were incomplete 
primary education, being single, and not receiving 
medical consultation in the last year. In Rio Grande 
do Sul, Southern Brazil, the most important factor for 
a low adherence to CC prevention was a low educa-
tion level,5 with a strong association between the 
presence of epithelial cell abnormality and education 
less than primary school. Borges et al4 conducted a 
population-based study in 2012 in the city of Rio 
Branco, AC, Northern Brazil and revealed that women 
without a stable relationship, with low income, and 
schooling only till the primary section presented a 
higher estimate of risk of not being tested.
Variables related to awareness of CC in women strongly 
correlated with adherence to the preventive program in 
this study. Although most respondents have correctly 
stated that the Pap test can prevent CC, only half have 
correctly stated the frequency of screening and when 
screening begins; only 16.6% were able to correlate 
HPV to CC. These data suggest that governmental 
actions aimed at improving the public’s awareness of 
CC can result in a more comprehensive, systematic, 
and effective model of care.
The cluster sampling method used is one of the limi-
tations of this study because it can fail to provide the 
appropriate representative of the population. Further, 
the cross-sectional design did not allow the use of 
temporality as a criterion for causality as risk factors, 
and outcome were measured at the same time and the 
bias of reverse causality cannot be eliminated. The 
issue is personal and intimate in nature, associated 
with the reproductive health of women, and may have 
influenced the results. However, the adopted sample 
size and correct survey procedures strengthen the reli-
ability of the data.
It is concluded that the coverage of the Boa Vista CC 
screening program was 85.6%, surpassing the WHO 
target for the control of this disease. However, special 
attention should be paid to the diagnostic quality of 
cervical cytology slides and therapeutic schedules of 
the positive cases in order to clarify barriers and lead to 
a more effective control of CC. The data also show that 
ignorance of the disease and prevention mechanisms 
are risk factors for non-adherence to the preventive 
programs for a considerable portion of the population, 
Table 2. Personal characteristics of the women (N = 517) 
who underwent the screening test in a successive three-year 
period. Boa Vista, RR, Northern Brazil, 2013.
Characteristic n %
When was the last preventative screening test?
Less than 1 year ago 443 85.7
2 years ago 73 14.3
3 years ago 0 0.0
What was the reason for the test?
Gynecological complaint 57 11.0
Prenatal care 20 3.9
Prevention campaigns 12 2.3
Undergo periodically 411 79.5
Opportunistic medical appointment 13 2.5
How often are they tested?
Once per year 398 77.0
Every 2 years 44 8.5
Every 3 years 6 1.2
5-10 years 4 0.8
Not sure 65 12.5
Did a health care professional direct them to undergo testing?
Yes 253 49.0
No 264 51.0
After being tested. did they return to get the results?
Yes 495 95.7
No 20 3.9
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particularly for low-income patients. Screening should 
be expanded to the society’s most vulnerable groups, 
and broad, effective, and realistic preventative strate-
gies should be designed.
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Table 3. Correlation between individual variables, knowledge among women, and non-completion of Pap smear in a successive 
three-year period in univariate and multivariate analyses. Boa Vista, RR, Northern Brazil, 2013.
Explanatory variables
Did not undergo 
screening in the last 3 
years (%)
p ORunivariate ORadjusted
Household income per capita ≤ R$1,000.00 16.6 < 0.001 3.1 (1.4-7.0) 2.8 (1.2-6.7)
Household income per capita > R$1,000.00 5.9 1 1
Had a medical visit in the last year 34 < 0.0001 0.2 (0.1-0.3) 0.4 (0.1-0.7)
No visit in the last year 8.8 1 1
Know the name of the virus that causes CC 6.0 < 0.01 0.3 (0.1-0.8) 0.5 (0.2-0.8)
Do not know 16.9 1 1
Know which test detects CC 13.2 0.02 0.3 (0.1-0.8) 0.5 (0.2-0.9)
Do not know 29.0 1 1
Know when screening begins 9.7 < 0.001 0.4 (0.2-0.7) 0.6 (0.2-0.8)
Do not know 19.7 1 1
Know that a vaccine to prevent CC exists 5.4 < 0.0001 0.2 (0.1-0.5) 0.6 (0.2-0.9)
Do not know 17.1 1 1
Age > 35 years 16.0 ns 0.7 (0.4-1.1) –
Age ≤ 35 years 12.0 1
Schooling till primary education 22.5 ns 2 (1.2-3.4) –
High school or beyond 12.4 1
Unmarried/Widowed/Separated status 15.7 ns 0.8 (0.5-1.2) –
Married or in a stable union 13.0 1
Receive government assistance 15.4 ns 1.7 (0.7-1.8) –
Do not receive government assistance 13.4 1
More than 5 family members in household 14.0 ns 0.9 (0.5-1.7) –
Up to 5 family members in household 14.3 1
Smoker 15.6 ns 1.1 (0.7-1.9) –
Non-smoker 13.7 1
Use alcohol 15.4 ns 1.1 (0.3-3.2) –
Do not use alcohol 14.2 1
Family history of CC 17.7 ns 1.3 (0.7-2.4) –
No family history of CC 13.6 1
Do not receive a home visit from health 
professional in the last year
14.1 ns 1.0 (0.6-1.8) –
Received a visit 14.8 1
Know how frequently screening is done 13.7 ns 0.9 (0.5-1.4) –
Do not know frequency 14.8 1
CC: cervical cancer; NS: not significant (p > 0.15) for univariate analysis
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